Home - Products - Microbiology/Virology - HBV - Metacavir

Metacavir

CAS No. 120503-45-9

Metacavir( —— )

Catalog No. M34334 CAS No. 120503-45-9

Metacavir (PNA) is a novel nucleoside reverse transcriptase inhibitor, a deoxyguanosine analog, with anti-hepatitis B virus (HBV) activity and mitochondrial toxicity, which can be used to study HBV infection.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	445	Get Quote
5MG	686	Get Quote
10MG	938	Get Quote
25MG	1398	Get Quote
50MG	1822	Get Quote
100MG	2484	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Metacavir
Note

Research use only, not for human use.
Brief Description

Metacavir (PNA) is a novel nucleoside reverse transcriptase inhibitor, a deoxyguanosine analog, with anti-hepatitis B virus (HBV) activity and mitochondrial toxicity, which can be used to study HBV infection.
Description

Metacavir (PNA) is a novel nucleoside reverse transcriptase inhibitor, a deoxyguanosine analog, with anti-hepatitis B virus (HBV) activity and mitochondrial toxicity, which can be used to study HBV infection.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Microbiology/Virology
Target

HBV
Recptor

HBV | Reverse Transcriptase
Research Area

——
Indication

——

Chemical Information

CAS Number

120503-45-9
Formula Weight

265.27
Molecular Formula

C11H15N5O3
Purity

>98% (HPLC)
Solubility

——
SMILES

O(C)C1=C2C(N(C=N2)[C@@H]3O[C@H](CO)CC3)=NC(N)=N1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

DVR-01

DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
Risedronate Sodium

Risedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis.
GLP-26

GLP-26 is a novel potent HBV capsid modulator that reduces secreted HBeAg in HepNTCPDL cells transfected with HBV wild type with EC50 of 0.7 uM.

Sign In Join Free